| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-19 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.38 | 8e-17 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.35 | 6e-15 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.27 | 7e-15 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-14 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.27 | 7e-14 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-13 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-12 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.34 | 4e-10 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.32 | 1e-09 |